Key TakeawaysEli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth 5billion.Thecompany′sstockwasupgradedbyDeutscheBankanalystsfollowingitsquarterlyresultslastweek.Lillysharesjumpedearlyinthedaybutclosedinthered.EliLilly(LLY)sharesfinishedMondaylowerafteraback−and−forthsessioninwhichananalystupgradesentthemhigherbeforenewsof5 billion in bond sales pulled them into the red. Deutsche Bank analysts called th ...